The UK Was the First in the World to Approve Covid Pills

Molnupiravir pills were developed by the American concern Merck in collaboration with Ridgeback Biotherapeutics, they block the enzyme necessary for the coronavirus to reproduce DNA. The UK has become the world’s first country to approve the use of pills from COVID-19 Lagevrio (Molnupiravir), a drug developed by American pharmaceutical companies Merck and Ridgeback Biotherapeutics. The drug has shown safety and effectiveness to reduce the risk of hospitalization and death of patients with mild and moderate COVID-19, who have an increased risk of developing a serious disease, the British Agency for Control of Medicines and Medical Devices reported on Thursday, November 4. In turn, British Health Minister Sajid Javid announced the country's historic day and pointed out that the kingdom became the world’s first country to approve an antiviral drug that can be used at home against COVID-19. He noted that the London authorities are working to provide certified medicine to patients. Molnupiravir pills should be started immediately after a positive test The principle of action of the drug Molnupiravir, developed by Merck & Co, together with Ridgeback Biotherapeutics for the treatment of coronavirus infection, is blocking a certain enzyme that the virus needs to reproduce its DNA. If possible, the medicine produced in the form of tablets should be taken immediately after a positive test for coronavirus, but no later than five days after the onset of symptoms. Merck plans to produce ten million doses of the drug by the end of this year, and another 20 million doses in 2022.